- Home
- VERO vs IBO Comparison
VERO vs IBO Comparison
Compare VERO & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERO
- IBO
- Stock Information
- Founded
- VERO N/A
- IBO 2018
- Country
- VERO Canada
- IBO United States
- Employees
- VERO N/A
- IBO N/A
- Industry
- VERO Medical/Dental Instruments
- IBO
- Sector
- VERO Health Care
- IBO
- Exchange
- VERO Nasdaq
- IBO NYSE
- Market Cap
- VERO 4.9M
- IBO 5.8M
- IPO Year
- VERO N/A
- IBO 2024
- Fundamental
- Price
- VERO $2.58
- IBO $0.70
- Analyst Decision
- VERO
- IBO
- Analyst Count
- VERO 0
- IBO 0
- Target Price
- VERO N/A
- IBO N/A
- AVG Volume (30 Days)
- VERO 1.1M
- IBO 735.6K
- Earning Date
- VERO 08-14-2025
- IBO 08-23-2025
- Dividend Yield
- VERO N/A
- IBO N/A
- EPS Growth
- VERO N/A
- IBO N/A
- EPS
- VERO N/A
- IBO N/A
- Revenue
- VERO $60,997,000.00
- IBO N/A
- Revenue This Year
- VERO N/A
- IBO N/A
- Revenue Next Year
- VERO $7.47
- IBO N/A
- P/E Ratio
- VERO N/A
- IBO N/A
- Revenue Growth
- VERO N/A
- IBO N/A
- 52 Week Low
- VERO $2.10
- IBO $0.36
- 52 Week High
- VERO $14.50
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- VERO 51.60
- IBO N/A
- Support Level
- VERO $2.42
- IBO N/A
- Resistance Level
- VERO $2.71
- IBO N/A
- Average True Range (ATR)
- VERO 0.17
- IBO 0.00
- MACD
- VERO -0.00
- IBO 0.00
- Stochastic Oscillator
- VERO 26.09
- IBO 0.00
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.